Discontinued Drugs
The Drugs.com Discontinued Drug Shortages List is a searchable database that provides up-to-date information related to drug discontinuations, sorted by generic name and latest revision date. The reason for the discontinuation and estimated resupply date, if available, is listed for each individual agent.
Current | Resolved | Discontinued
| Generic Name |
Revision Date |
|
Abciximab Injection
|
April 29, 2019 |
|
Ammonium Chloride Injection
|
January 31, 2017 |
|
Ammonium Molybdate Injection
|
September 26, 2018 |
|
Bacitracin for Injection
|
March 4, 2020 |
|
Barium Sulfate 0.1% Oral Suspension
|
June 20, 2024 |
|
Bezlotoxumab Injection
|
February 5, 2025 |
|
Boceprevir Capsules
|
January 6, 2016 |
|
Bupivacaine Hydrochloride Implant
|
April 11, 2025 |
|
Carbidopa and Levodopa Orally Disintegrating Tablets
|
September 27, 2023 |
|
Carisoprodol and Aspirin
|
May 22, 2017 |
|
Cimetidine Oral Solution
|
May 24, 2023 |
|
Cortisone Tablets
|
April 8, 2022 |
|
Cytarabine Liposomal Injection
|
December 19, 2017 |
|
Desmopressin Rhinal Tubes
|
May 24, 2021 |
|
Dexpanthenol Injection
|
September 24, 2018 |
|
Diphenoxylate Hydrochloride and Atropine Hydrochloride Oral Solution
|
November 8, 2024 |
|
Echothiophate Iodide Ophthalmic Drops
|
February 9, 2021 |
|
Edrophonium Injection
|
December 29, 2017 |
|
Electrolyte Concentrate
|
February 12, 2018 |
|
Exenatide Injection
|
November 18, 2024 |
|
Ezetimibe and Atorvastatin Tablets
|
May 8, 2018 |
|
Fluorescein Sodium Ophthalmic Strips
|
August 20, 2024 |
|
Isosorbide Dinitrate Extended-Release Capsules
|
January 21, 2021 |
|
Isosorbide Dinitrate Extended-Release Tablets
|
September 21, 2018 |
|
Liotrix (Levothyroxine/Liothyronine T4/T3)
|
February 11, 2019 |
|
Maprotiline Tablets
|
September 10, 2021 |
|
Methyldopa Tablets
|
November 2, 2023 |
|
Methyldopate Injection
|
September 24, 2018 |
|
Morrhuate Sodium Injection
|
September 24, 2018 |
|
Multivitamin Oral Liquid
|
November 15, 2016 |
|
Mupirocin Calcium 2% Nasal Ointment
|
July 14, 2020 |
|
Nesiritide Injection
|
June 20, 2018 |
|
Nicotine Inhalation System
|
November 1, 2023 |
|
Posaconazole Oral Suspension
|
January 8, 2024 |
|
Promethazine, Phenylephrine, and Codeine Oral Solution
|
September 24, 2024 |
|
Quinidine Gluconate Injection
|
March 4, 2020 |
|
Ranitidine Injection
|
April 2, 2020 |
|
Reserpine Oral Tablets
|
April 15, 2016 |
|
Ritonavir Oral Solution
|
February 13, 2023 |
|
Synthetic Conjugated Estrogen
|
August 5, 2016 |
|
Torsemide Injection
|
September 24, 2018 |
|
Trimethobenzamide Capsules
|
November 30, 2023 |
|
Typhoid Live Oral Vaccine
|
January 23, 2023 |
|
Vitamin E Aqueous Oral Solution
|
January 25, 2017 |
Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah, provided by ASHP as its exclusive authorized distributor, and used with permission. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Medical Disclaimer
